HTLV-II infection in a Liverpool intravenous drug user

Methodology and scope of peer-reviewed evaluations of TB programmes in high-incidence settings: a scoping review.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026

Early interventions reduce multimorbidity and TB disability in Kenya, Uganda, Zambia, and Zimbabwe.

IJTLD open·2026

Operational research to End TB: 2nd edition of the Union's Guide to operational research.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025

Kartagener Syndrome: A First Report of Two Cases from Benin, West Africa.

West African journal of medicine·2025

Evaluating disability, comorbidities and risk factors after TB treatment: an 18-24 month follow-up.

IJTLD open·2025

TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe.

IJTLD open·2025

Clinical and population genomic epidemiology of invasive group A streptococcus in Scotland, 2014-2024.

The Journal of infection·2026

Global epidemiology, clinical burden, and antimicrobial resistance of the WHO priority pathogens: An updated review focusing on understudied non-baumannii Acinetobacter and emerging extensively drug-resistant threats.

The Journal of infection·2026

Phase 2 evaluation of two GEO-CM04S1 dose levels shows comparable safety and broad immunogenicity.

The Journal of infection·2026

Epidemiological trends, health inequality, and forecasting of Brucellosis in Mainland China, 2004-2030.

The Journal of infection·2026

Epidemiology and outcomes of Group A streptococcal and non-Group A streptococcal septic arthritis in French children between 2010 and 2023, a national cohort analysis, and case-control study.

The Journal of infection·2026

Dual-species interactions with intestinal bacteria drive multi-drug resistance in Campylobacter.

The Journal of infection·2026

RNA virome comparison between sylvatic and urban-interface mosquitoes from Southeastern Brazil.

Frontiers in cellular and infection microbiology·2026

Mpox in the Republic of Korea from 2022 to June 2026: Epidemiological Trends and the First Clade Ib Case.

Public health weekly report·2026

Cardiac MRI-guided therapeutics in ischemic cardiomyopathy: impact on heart-team consensus and outcomes.

Frontiers in cardiovascular medicine·2026

Re-evaluating variability of circulating miR-122 in healthy volunteers: Implications for biomarker qualification in drug-induced liver injury.

British journal of clinical pharmacology·2026

Divergent host adaptation in Marburg virus: a hypothesis-generating framework for prioritizing non-traditional reservoirs.

BMC genomics·2026

MicroRNA-122 as a regulator and biomarker of liver disease.

Journal of molecular medicine (Berlin, Germany)·2026

Related Experiment Videos

HTLV-II infection in a Liverpool intravenous drug user

Related Concept Videos

Methodology and scope of peer-reviewed evaluations of TB programmes in high-incidence settings: a scoping review.

Early interventions reduce multimorbidity and TB disability in Kenya, Uganda, Zambia, and Zimbabwe.

Operational research to End TB: 2nd edition of the Union's Guide to operational research.

Kartagener Syndrome: A First Report of Two Cases from Benin, West Africa.

Evaluating disability, comorbidities and risk factors after TB treatment: an 18-24 month follow-up.

TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe.

Clinical and population genomic epidemiology of invasive group A streptococcus in Scotland, 2014-2024.

Global epidemiology, clinical burden, and antimicrobial resistance of the WHO priority pathogens: An updated review focusing on understudied non-baumannii Acinetobacter and emerging extensively drug-resistant threats.

Phase 2 evaluation of two GEO-CM04S1 dose levels shows comparable safety and broad immunogenicity.

Epidemiological trends, health inequality, and forecasting of Brucellosis in Mainland China, 2004-2030.

Epidemiology and outcomes of Group A streptococcal and non-Group A streptococcal septic arthritis in French children between 2010 and 2023, a national cohort analysis, and case-control study.

Dual-species interactions with intestinal bacteria drive multi-drug resistance in Campylobacter.

RNA virome comparison between sylvatic and urban-interface mosquitoes from Southeastern Brazil.

Mpox in the Republic of Korea from 2022 to June 2026: Epidemiological Trends and the First Clade Ib Case.

Cardiac MRI-guided therapeutics in ischemic cardiomyopathy: impact on heart-team consensus and outcomes.

Re-evaluating variability of circulating miR-122 in healthy volunteers: Implications for biomarker qualification in drug-induced liver injury.

Divergent host adaptation in Marburg virus: a hypothesis-generating framework for prioritizing non-traditional reservoirs.

MicroRNA-122 as a regulator and biomarker of liver disease.

Related Experiment Videos

HTLV-II infection in a Liverpool intravenous drug user

Related Concept Videos

Related Articles